Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine

Neuropharmacology

Volumn 37, Issue 1, 1998, Pages 103-111

  Rowell, Peter P ^a   Duggan, Deborah S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Acetylcholine receptor; Desensitization; Dopamine release; Inactivation; Nicotine; Nicotinic

Indexed keywords

CHOLINERGIC RECEPTOR; DOPAMINE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SMOKING CESSATION;

ANIMALS; DOPAMINE; MALE; NEOSTRIATUM; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SYNAPTOSOMES;

EID: 0031836531     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00193-7     Document Type: Article

References (61)

1. Aoshima H. A second, slower inactivation process in acetylcholine receptor-rich membrane vesicles prepared from electrophorus electricus. Arch. Biochem. Biophys. 235:1984;312-318.
2. Benowitz N.L. Pharmacokinetic considerations in understanding nicotine dependence. Bock G., Marsh J. The Biology of Nicotine Dependence. 1990;186-200 Wiley, Ciba Foundation Symposium 152, New York.
3. Benowitz N.L., Zevin S., Jacob P III Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine and cigarette smoking. Br. J. Clin. Pharmacol. 43:1997;259-267.
4. 3H)nicotine binding sites in human brain. J. Neurochem. 50:1988;1243-1247.
5. Brazell M.P., Mitchell S.N., Joseph M.H., Gray J.A. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology. 29:1990;1177-1185.
6. 3H]nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther. 282:1997;7-13.
7. Bridges R.B., Combs J.G., Humble J.W., Turbek J.A., Rehm S.R., Haley N.J. Population characteristics and cigarette yield as determinants of smoke exposure. Pharmacol. Biochem. Behav. 37:1990;17-28.
8. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. A new a-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271:1996;7522-7528.
9. Clarke P.B.S. Mesolimbic dopamine activation-the key to nicotine reinforcement? Bock G., Marsh J. The Biology of Nicotine Dependence. 1990;153-162 Wiley, Chichester, UK.
10. Collins A.C. An analysis of the addiction liability of nicotine. Adv. Alcohol Subst. Abuse. 9:1990;83-101.
11. Damsma G., Westerink B.H.C., deVries J.B., Horn A.S. The effect of systemically applied cholinergic drugs on the striatal release of dopamine and its metabolites as determined by automated brain dialysis in conscious rats. Neurosci. Lett. 89:1988;349-354.
12. Del Castillo J., Webb G.D. Rapid desensitization of acetylcholine receptors of eel electroplaque following iontophoretic application of agonist compounds. J. Physiol. 270:1977;271-282.
13. DeSarno P., Giacobini E. Modulation of acetylcholine release by nicotinic receptors in the rat brain. J. Neurosci. Res. 22:1989;194-200.
14. Egan T.M., North R.A. Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro. Neuroscience. 19:1986;565-571.
15. El-Bizri H., Clarke P.B. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br. J. Pharmacol. 111:1994;406-413.
16. Feltz A., Trautmann A. Desensitization at the frog neuromuscular junction: a biphasic process. J. Physiol. 322:1982;257-272.
17. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59:1992;848-856.
18. 3H]dopamine release from mouse striatal synaptosomes. J. Neurochem. 62:1994;1390-1398.
19. 3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. J. Pharmacol. Exp. Ther. 282:1997;32-43.
20. Henningfield J.E., Stapleton J.M., Benowitz N.L., Grayson R.F., London E.D. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 33:1993;23-29.
21. 3H-nicotine binding on bovine adrenal chromaffin cells. J. Neurosci. 8:1988;1436-1446.
22. Hsu Y.N., Edwards S.C., Wecker L. Sustained nicotine exposure increases phosphorylation of the α4 subunit of α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes by both cyclic AMP-dependent protein kinase and a tyrosine kinase. Soc. Neurosci. Abstracts. 22:1996a;1526.
23. Hsu Y.N., Amin J., Weiss D.S., Wecker L. Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66:1996b;667-675.
24. Huganir R.L., Greengard P. Regulation of receptor function by protein phosphorylation. Trends Pharmacol. Sci. 8:1987;472-477.
25. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 16(132):1986;337-338.
26. Jaffe J.H. Tobacco smoking and nicotine dependence. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine Psychopharmacology. 1990;1-37 Oxford University Press, New York.
27. Jones M.V., Westbrook G.L. The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci. 19:1996;96-101.
28. Katz B., Thesleff S. A study of desensitization produced by acetylcholine at the motor end plate. J. Physiol. 138:1957;63-80.
29. Kulak J.M., Nguyen T.A., Olivera B.M., McIntosh J.M. α-Conotoxin II blocks nicotine-stimulated dopamine release from rat striatal synaptosomes. J. Neurosci. 17:1997;5263-5270.
30. Langley J.N., Dickinson W.L. On the progressive paralysis of the different classes of nerve cells in the superior cervical ganglion. Proc. R. Soc. London. 47:1890;379-389.
31. Lena C., Changeux J.P. Allosteric modulation of the nicotinic acetylcholine receptor. Trends Neurosci. 16:1993;181-186.
32. Levitan I.B. Modulation of ion channels by protein phosphorylation and dephosphorylation. Ann. Rev. Physiol. 56:1994;193-212.
33. Lippiello P.M., Bencherif M., Prince R.J. The role of desensitization in CNS nicotinic receptor function. Clarke P.B.S., Quik M., Adlkofer F., Thurau K. Effects of Nicotine in Biological Systems II. 1995;79-85 Birkhauser Verlag, Basel.
34. Lukas R.J. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line. J. Neurochem. 56:1991;1134-1145.
35. + efflux from mouse brain synaptosomes. J. Neurochem. 63:1994;2125-2135.
36. Mifsud J.C., Hernandez L., Hoebel B.G. Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res. 478:1989;365-367.
37. Monod J., Wyman J., Changeux J.P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12:1965;88-118.
38. Nakayama H., Okuda H., Nakashima T. Phosphorylation of rat brain nicotinic acetylcholine receptor by cAMP-dependent protein kinase in vitro. Brain Res.-Mol. Brain Res. 20:1993;171-177.
39. Ochoa E.L., Chattopadhyay A., McNamee M.G. Desensitization of the nicotinic acetylcholine receptor: molecular, mechanisms and effect of modulators. Cell. Mol. Neurobiol. 9:1989;141-178.
40. Ochoa E.L., Li L., McNamee M.G. Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Mol. Neurobiol. 4:1990;251-287.
41. Pich E.M., Pagliusi S.R., Tessari M., Talabot-Ayer D., Hooft van Huijsduijnen R., Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science. 275:1997;83-86.
42. Pomerleau O.F., Pomerleau G.A. Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci. Biobehav. Rev. 8:1984;503-513.
43. Rang H.P., Ritter J.M. On the mechanism of desensitization at cholinergic receptors. Mol. Pharmacol. 6:1970;357-382.
44. Rapier C., Lunt G.G., Wonnacott S. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J Neurochem. 50:1988;1123-1130.
45. 3H]dopamine release from striatal synaptosomes: pharmacological characterization. J. Neurochem. 54:1990;937-945.
46. Robinson D., McGee R. Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells. Mol. Pharmacol. 27:1985;409-417.
47. Rosecrans J.A., Karan L.D. Neurobehavioral mechanisms of nicotine action: role in the initiation and maintenance of tobacco dependence. J. Subst. Abuse Treat. 10:1993;161-170.
48. 3H]dopamine from rat striatal synaptosomes. Neurosci. Lett. 189:1995;171-175.
49. Rowell P.P., Hillebrand J.A. Desensitization of nicotine-stimulated dopamine release from rat striatal synaptosomes. J. Neurochem. 63:1994;561-569.
50. 3H]dopamine release by nicotine in rat nucleus accumbens. J. Neurochem. 49:1987;1449-1454.
51. Rowell P.P., Li M. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J. Neurochem. 68:1997;1982-1989.
52. Rozental R., Aracava G.T., Scoble K.L., Swanson S., Wonnacott S., Albuquerque E.X. Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine. J. Pharmacol. Exp. Ther. 251:1989;395-404.
53. Russell M.A.H. Nicotine intake and its control over smoking. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine Psychopharmacology, Molecular, Cellular and Behavioural Aspects. 1990;374-418 Oxford University Press, Oxford.
54. Siegel H.N., Lukas R.J. Nicotinic agonists regulate a-bungarotoxin binding sites in TE671 human medulloblastoma cells. J. Neurochem. 50:1988;1272-1278.
55. Simasko S.M., Soares J.R., Weiland G.A. Two components of carbamylcholine-induced loss of nicotinic acetylcholine receptor function in the neuronal cell line PC12. Mol. Pharmacol. 30:1986;6-12.
56. 3H]dopamine release from rat striatal synaptosomes. J. Neurochem. 67:1996;163-170.
57. Swope S.L., Qu Z., Huganir R.L. Phosphorylation of the nicotinic acetylcholine receptor by protein tyrosine kinase. Ann. NY Acad. Sci. 757:1995;197-214.
58. Vibat C.R., Lasalde J.A., McNamee M.G., Ochoa E.L. Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus laevis oocytes. Cell. Mol. Neurobiol. 15:1995;411-425.
59. Westfall T.C., Mereu G., Vickery L., Perry H., Naes L., Yoon K.P. Regulation by nicotine of midbrain dopamine neurons. Prog. Brain Res. 79:1989;173-185.
60. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19:1996;319-340.
61. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.